Ji, Y.; Li, X.; Qi, Y.; Zhao, J.; Zhang, W.; Qu, P.
Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo. Molecules 2022, 27, 8873.
https://doi.org/10.3390/molecules27248873
AMA Style
Ji Y, Li X, Qi Y, Zhao J, Zhang W, Qu P.
Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo. Molecules. 2022; 27(24):8873.
https://doi.org/10.3390/molecules27248873
Chicago/Turabian Style
Ji, Yurou, Xinyu Li, Yue Qi, Jianguo Zhao, Wenwen Zhang, and Pengpeng Qu.
2022. "Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo" Molecules 27, no. 24: 8873.
https://doi.org/10.3390/molecules27248873
APA Style
Ji, Y., Li, X., Qi, Y., Zhao, J., Zhang, W., & Qu, P.
(2022). Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo. Molecules, 27(24), 8873.
https://doi.org/10.3390/molecules27248873